evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

1,733 questions · 1,794 findings · 326 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 243 · 13.5%GRADE not reported 96 · 5.4%Very low 597 · 33.3%Low 506 · 28.2%Moderate 303 · 16.9%High 49 · 2.7%

Retropubic bottom‐to‐top approach vs retropubic top‐to‐bottom approach

Subjective cure within 12 months · women with stress urinary incontinence

Retropubic bottom‐to‐top approach probably leads to higher subjective cure (short term, ≤ 1 year) compared with retropubic top‐to‐bottom approach (moderate certainty).

1 finding from 1 review

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

Subjective cure within 12 months · women with stress urinary incontinence

Obturator medial‐to‐lateral approach showed no clear difference in subjective cure (short term ≤ 1 year) compared with obturator lateral‐to‐medial approach (low certainty).

1 finding from 1 review

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

Voiding dysfunction · women with stress urinary incontinence

Obturator medial‐to‐lateral approach probably leads to higher voiding dysfunction (short and medium term, up to 5 years) compared with obturator lateral‐to‐medial approach (moderate certainty).

1 finding from 1 review

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

Denovo urgency or urgency incontinence · women with stress urinary incontinence

Obturator medial‐to‐lateral approach showed no clear difference in de novo urgency or urgency incontinence (short term, up to 12 months) compared with obturator lateral‐to‐medial approach (low certainty).

1 finding from 1 review

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

Vaginal tape erosion · women with stress urinary incontinence

It is very uncertain whether obturator medial‐to‐lateral approach changes vaginal tape erosion (short and medium term, up to 5 years) compared with obturator lateral‐to‐medial approach (very low certainty).

1 finding from 1 review

Obturator medial‐to‐lateral approach vs obturator lateral‐to‐medial approach

Repeat surgery for urinary incontinence · women with stress urinary incontinence

Obturator medial‐to‐lateral approach showed no clear difference in repeat incontinence surgery (short term, up to 12 months) compared with obturator lateral‐to‐medial approach (low certainty).

1 finding from 1 review

Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy

Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery · patients with gynaecological malignancies

Retroperitoneal drainage showed no clear difference in short‐term lymphocyst formation: both asymptomatic and symptomatic… compared with no drainage after pelvic lymphadenectomy (moderate certainty).

1 finding from 1 review

Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy

Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery · patients with gynaecological malignancies

Retroperitoneal drainage leads to higher short‐term lymphocyst formation: symptomatic within 4 weeks after… compared with no drainage after pelvic lymphadenectomy (high certainty).

1 finding from 1 review

Retroperitoneal drainage vs no drainage after pelvic lymphadenectomy

Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery · patients with gynaecological malignancies

Retroperitoneal drainage showed no clear difference in short‐term lymphocyst formation: both asymptomatic and symptomatic… compared with no drainage after pelvic lymphadenectomy (high certainty).

1 finding from 1 review

CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) vs MEDIUM DOSE (401 mg/day to 800 mg/day)

Global state: no improvement ‐ short term · patients with schizophrenia

It is very uncertain whether CHLORPROMAZINE LOW DOSE (≤ 400 mg/day) changes global state: no improvement ‐ short term compared with MEDIUM DOSE (401 mg/day to 800 mg/day) (very low certainty).

1 finding from 1 review